ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENT
Clinical trials for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENT explained in plain language.
Never miss a new study
Get alerted when new ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENT trials appear
Sign up with your email to follow new studies for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New chemo cocktail aims to boost stem cell transplant success in leukemia
Disease control Not yet recruitingThis trial is testing a combination of three chemotherapy drugs—clofarabine, busulfan, and melphalan—given before a stem cell transplant in 30 adults with acute myeloid leukemia (AML) who are in first remission. The goal is to see if this conditioning regimen improves survival an…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENT
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New blood tests could sharpen CMV monitoring in transplant patients
Knowledge-focused Not yet recruitingThis study looks at whether measuring two new viral markers (CMV-RNA and TTV-DNA) in the blood can give a clearer picture of CMV infection in patients who have had a stem cell transplant and are taking the drug letermovir to prevent CMV. Researchers will track 290 adult transplan…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENT
Sponsor: University of Rome Tor Vergata • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC